Pfizer to buy cancer drug firm Medivation for $14bn
Aug 22
US pharmaceutical giant Pfizer confirms it will buy a cancer drug firm Medivation for about $14bn (£10.7bn).
Read more
Aug 22
US pharmaceutical giant Pfizer confirms it will buy a cancer drug firm Medivation for about $14bn (£10.7bn).
Read more